Efficacia dell’ossigenoterapia con le cannule nasali ad alto flusso nella prevenzione della reintubazione del paziente critico: revisione della letteratura

Filippo Binda, Marco Iotti, Ileana Adamini, Alessandro Galazzi

Abstract

Introduzione: l’insufficienza respiratoria post-estubazione si verificain circa il 10-20% dei pazienti sottoposti a estubazione programmata che necessitano la reintubazione entro 48-72 ore. L’ossigenoterapiacon le cannule nasali ad alto flusso (HFNC) o la ventilazione non inva- siva (NIPPV) possono ridurre il rischio di reintubazione.

Riferimenti bibliografici

Thille AW, Boissier F, Ben Ghezala H, et al. Risk factors for and prediction by caregivers of extubation failure in ICU patients: a prospective study. Crit Care Med. 2015;43(3):613-20.

Frutos-Vivar F, Ferguson ND, Esteban A, et al. Risk factors for extubation failure in patients following a successful spontaneous breathing trial. Chest. 2006;130(6):1664-71.

Thille AW, Harrois A, Schortgen F, et al. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med 2011;39:2612-18.

Frutos-Vivar F, Esteban A, Apezteguia C, et al. Outcome of reintubated patients after scheduled extubation. J Crit Care 2011;26:502-509.

Burns KE, Meade MO, Premji A, et al. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev. 2013;12:CD004127.

Ferrer M, Sellarés J, Valencia M, et al. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet. 2009; 374(9695):1082-8.

Schmidt GA, Girard TD, Kress JP, et al. Liberation from mechanical ventilation in critically ill adults: executive summary of an official American Thoracic Society clinical practice guideline. Chest. 2017;151(1):160-5.

Hill NS. Complications of noninvasive ventilation. Respir Care. 2000; 45(5):480-1.

Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 2004;350:2452-2460.

Lee JH, Rehder KJ, Williford L, et al. Use of high-flow nasal cannula in critically ill infants, children and adults: a critical review of the literature. Intensive Care Med. 2013; 39(2):247-57.

Ward JJ. High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respir Care 2013;58:98-122.

Fernandez R, Subira C, Frutos-Vivar F, et al. High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial. Ann Intensive Care. 2017;7(1):47.

Moher D, Liberati A, Tetzlaff J, et al. Linee guida per il reporting di revisioni sistematiche e meta-analisi: il PRISMA Statement. Evidence. 2015;7(6).

Schulz KF, Altman DG, Moher D, the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010 Mar;8(1):18.

Maggiore SM, Idone FA, Vaschetto R, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282-8.

Hernández G, Vaquero C, González P, et al. Effect of post-extubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low risk patients: a randomized clinical trial. JAMA. 2016;315(13):1354-61.

Hernández G, Vaquero C, Colinas L, et al. Effect of post-extubation high-flow nasal cannula vs noninvasive ventilation on reintubation and post-extubation respiratory failure in high risk patients: a randomized clinical trial. JAMA. 2016;316(15):1565-74.

Stéphan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA. 2015;313(23):2331-9.

Futier E, Paugam-Burtz C, Godet T, et al. Effect of early post-extubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomized controlled trial. Intensive Care Med. 2016;42(12):1888-98.

Song H-Z, Gu J-X, Xiu H-Q, et al. The value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure. Clinics. 2017;72(9):562-567.

Nedel WL, Deutschendorf C, Moraes Rodrigues Filho E. High-flow nasal cannula in critically ill subjects with or at risk for respiratory failure: a systematic review and meta-analysis. Respir Care. 2017;62(1):123–32.

Corley A, Rickard CM, Aitken LM, et al. High-flow nasal cannula for respiratory support in adult intensive care patients. Cochrane Database Syst Rev. 2017;5:CD010172.

Nugent K. Post-extubation management of patients at high risk for reintubation. J Thorac Dis 2016;8(12):E1679-E1682.

Rabbat A, Blanc K, Lefebvre A, et. al Nasal high flow oxygen therapy after extubation: the road is open but don’t drive too fast! J Thorac Dis 2016;8(12):E1620-E1624.

Mauri T, Galazzi A, Binda F et al. Impact of flow and temperature on patient comfort during respiratory support by high-flow nasal cannula. Crit Care. 2018;22(1):120.

Thille AW, Contou D, Fragnoli C, et al. Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care 2013;17:R269.

Frat J-P, Brugiere B, Ragot S, et al. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care 2015;60(2):170-8.

Refback

  • Non ci sono refbacks, per ora.